Does botulinum toxin have a role in the management of myofascial pain?

Anesthesiology

Volumn 103, Issue 2, 2005, Pages 223-224

  Abram, Stephen E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; CALCITONIN GENE RELATED PEPTIDE; SNARE PROTEIN; SUBSTANCE P;

BLEPHAROSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSTONIA; EDITORIAL; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERHIDROSIS; INJECTION SITE; MAJOR CLINICAL STUDY; MYOCLONUS; MYOFASCIAL PAIN; NEUROTRANSMISSION; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; SPASTICITY; STRABISMUS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 23044475019     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200508000-00003     Document Type: Editorial

References (7)

1. Charles PD: Botulinum ncurotoxin serotype A: A clinical update on non-cosmetic uses. Am J Health Syst Pharm 2004; 61 (suppl6):S11-23
2. Ferrante FM, Bearn L, Rothrock R, King L: Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. ANESTHESIOLOGY 2005; 103:377-83
3. Wenzel RG: Pharmacology of botulinum neurotoxin serotype A. Am J Health Syst Pharm 2004; (suppl 6):S5-10
4. Durham PL, Cady R, Cady R: Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy. Headache 2004; 44:35-42
5. Foster L, Clapp L, Erickson M, Jabbari B: Botulinum toxin A and chronic low back pain: A randomized double blind study. Neurology 2001; 56:1290-3
6. Voller B, Sycha T, Gustorrf B, Schmetterer L, Lehr S, Eichler HG, Auff E, Schnider P: A randomized double-blind placebo controlled study on the analgesic effects of botulinum toxin A. Neurology 2003; 61:940-4
7. Blersch W, Schulte-Mattler WJ, Prswara S, May A, Bigalke H, Wohlfarth K: Botulinum toxin A and the cutaneous nociception in humans: A prospective double-blind placebo-controlled randomized study. J Neurol Sci 2002; 205:59-63